Norbinaltorphimine-dihydrochloride-nor-Binaltorphimine-dihydrochloride-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁
Norbinaltorphimine-dihydrochloride-nor-Binaltorphimine-dihydrochloride-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁
Norbinaltorphimine-dihydrochloride-nor-Binaltorphimine-dihydrochloride-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁
Norbinaltorphimine-dihydrochloride-nor-Binaltorphimine-dihydrochloride-DataSheet-生命科學(xué)試劑-MedChemExpress_第4頁
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

Hotline:400-820-3792Inhibitors?ScreeningLibraries?Proteinswww.MedChemENorbinaltorphiminedihydrochlorideCat.No.:HY-100903CASNo.:113158-34-2Synonyms:nor-Binaltorphiminedihydrochloride;nor-BNIdihydrochloride分?式:C??H??Cl?N?O?分?量:734.71作?靶點(diǎn):OpioidReceptor作?通路:GPCR/GProtein;NeuronalSignaling儲(chǔ)存?式:4°C,sealedstorage,awayfrommoisture*Insolvent:-80°C,6months;-20°C,1month(sealed

storage,awayfrommoisture)溶解性數(shù)據(jù)體外實(shí)驗(yàn)DMSO:100mg/mL(136.11mM;Needultrasonic)MassSolvent1mg5mg10mgConcentration制備儲(chǔ)備液1mM1.3611mL6.8054mL13.6108mL5mM0.2722mL1.3611mL2.7222mL10mM0.1361mL0.6805mL1.3611mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;?旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。儲(chǔ)備液的保存?式和期限:-80°C,6months;-20°C,1month(sealedstorage,awayfrommoisture)。-80°C儲(chǔ)存時(shí),請(qǐng)?jiān)?個(gè)?內(nèi)使?,-20°C儲(chǔ)存時(shí),請(qǐng)?jiān)?個(gè)?內(nèi)使?。體內(nèi)實(shí)驗(yàn)請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥?式選擇適當(dāng)?shù)娜芙?案。以下溶解?案都請(qǐng)先按照InVitro?式配制澄的儲(chǔ)備液,再依次添加助溶劑:(為保證實(shí)驗(yàn)結(jié)果的可靠性,澄的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的?作液,建議您現(xiàn)?現(xiàn)配,當(dāng)天使?;以下溶劑前顯?的百分?指該溶劑在您配制終溶液中的體積占?;如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過加熱和/或超聲的?式助溶)1.請(qǐng)依序添加每種溶劑:10%DMSO>>40%PEG300>>5%Tween-80>>45%salineSolubility:≥2.5mg/mL(3.40mM);Clearsolution1/3MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemE2.請(qǐng)依序添加每種溶劑:10%DMSO>>90%(20%SBE-β-CDinsaline)Solubility:≥2.5mg/mL(3.40mM);ClearsolutionBIOLOGICALACTIVITY?物活性Norbinaltorphiminedihydrochloride?種有效的和選擇性的κ阿?受體(κopioidreceptor)拮抗劑。IC50&Targetκopioidreceptor[1]體外研究NorbinaltorphiminereversiblyantagonizetheeffectsofκagonistswithpA2valuesof10.2-10.4.Norbinaltorphimineismuchlesspotentasanantagonistatμandδreceptors,pA2valuesare7.4-7.6and7.6-7.8,respectively[1].體內(nèi)研究NorbinaltorphiminehasweakandinconsistenteffectsonTHC-inducedtasteavoidanceinadolescentratsinthatNorbinaltorphiminebothattenuatesandstrengthenstasteavoidancedependentondoseandtrial.Norbinaltorphiminehaslimitedimpactonthefinalone-bottleavoidanceandnoeffectsonthetwo-bottlepreferencetest.Interestingly,NorbinaltorphiminehasnoeffectonTHC-inducedtasteavoidanceinadultratsaswell[2].Norbinaltorphiminepretreatmentsignificantlyattenuatesstress-inducedreinstatementofnicotine-CPP,buthasnoeffectonnicotine-primedreinstatement[3].PROTOCOLAnimalRats[2]Administration[2][3]NorbinaltorphimineisdissolvedinsterileH2Oataconcentrationof15mg/mLandadministeredsubcutaneously(SC)atadoseof15mg/kg.MaleSpragueDawleyratsarerankedaccordingtoaveragewaterconsumptiononallhabituationcyclesandassignedtooneoftwogroups[Norbinaltorphimine(n=42)andVehicle(n=42)],suchthatmeanwaterintakeiscomparableamonggroups.OnPND34(approximately24hpriortoconditioning,seebelow),subjectsassignedtotheNorbinaltorphiminegroupareinjectedwithNorbinaltorphimine(15mg/kg)andsubjectsassignedtotheVehiclegroupareinjectedwiththeNorbinaltorphiminevehicleatanequalvolume[2].Mice[3]Miceareconditionedwith0.5mg/kgnicotine,injectedsubcutaneously(s.c.)for3daysandtestedinthenicotine-conditionedplacepreference(CPP)model.After3daysextinction,Norbinaltorphimine(10mg/kg,s.c.)isadministered16hpriortoaprimingdoseofnicotine(0.1mg/kg,s.c.),andmicearetestedintheCPPmodelfornicotine-inducedreinstatementofCPP.Aseparategroupofmiceissubjectedtoa2-daymodifiedforcedswimtest(FST)paradigmtoinducestressafter3daysextinctionfromCPP.MicearegivenvehicleorNorbinaltorphimine(10mg/kg,s.c.)16hpriortoeachFSTsession[3].MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.戶使?本產(chǎn)品發(fā)表的科研?獻(xiàn)?FrontImmunol.2021Jul7;12:692286.2/3MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemE?FrontCellNeurosci.2022Jun2;16:894886.?Aging.2021May20;13(10):14355-14371.Seemorecustomervalidationsonwww.MedChemEREFERENCES[1].BirchPJ,etal.Norbinaltorphimine:antagonistprofileatkappaopioidreceptors.EurJPharmacol.1987Dec15;144(3):405-8.[2].FlaxSM,etal.Effectofnorbinaltorphimineon??-tetrahydrocannabinol(THC)-inducedtasteavoidanceinadolescentandadultSprague-Dawleyrats.Psychopharmacology(Berl).2015Sep;232(17):3193-201.[3].JacksonKJ,etal.Effectsofthekappaopioidreceptorantagonist,norbinaltorphimine,onstressanddrug-inducedreinstatementofnicotine-conditionedplacepreferenceinmice.Psychopharmacology(Berl).2013Apr;

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論